Anti-KIAA1958 monoclonal antibody

Pre-made anti-KIAA1958 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KIAA1958/KIAA1958 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2559-Ab-1/ GM-Tg-hg-IP2559-Ab-2Anti-Human KIAA1958 monoclonal antibodyHuman
GM-Tg-rg-IP2559-Ab-1/ GM-Tg-rg-IP2559-Ab-2Anti-Rat KIAA1958 monoclonal antibodyRat
GM-Tg-mg-IP2559-Ab-1/ GM-Tg-mg-IP2559-Ab-2Anti-Mouse KIAA1958 monoclonal antibodyMouse
GM-Tg-cynog-IP2559-Ab-1/ GM-Tg-cynog-IP2559-Ab-2Anti-Cynomolgus/ Rhesus macaque KIAA1958 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2559-Ab-1/ GM-Tg-felg-IP2559-Ab-2Anti-Feline KIAA1958 monoclonal antibodyFeline
GM-Tg-cang-IP2559-Ab-1/ GM-Tg-cang-IP2559-Ab-2Anti-Canine KIAA1958 monoclonal antibodyCanine
GM-Tg-bovg-IP2559-Ab-1/ GM-Tg-bovg-IP2559-Ab-2Anti-Bovine KIAA1958 monoclonal antibodyBovine
GM-Tg-equg-IP2559-Ab-1/ GM-Tg-equg-IP2559-Ab-2Anti-Equine KIAA1958 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2559-Ab-1/ GM-Tg-hg-IP2559-Ab-2; GM-Tg-rg-IP2559-Ab-1/ GM-Tg-rg-IP2559-Ab-2;
GM-Tg-mg-IP2559-Ab-1/ GM-Tg-mg-IP2559-Ab-2; GM-Tg-cynog-IP2559-Ab-1/ GM-Tg-cynog-IP2559-Ab-2;
GM-Tg-felg-IP2559-Ab-1/ GM-Tg-felg-IP2559-Ab-2; GM-Tg-cang-IP2559-Ab-1/ GM-Tg-cang-IP2559-Ab-2;
GM-Tg-bovg-IP2559-Ab-1/ GM-Tg-bovg-IP2559-Ab-2; GM-Tg-equg-IP2559-Ab-1/ GM-Tg-equg-IP2559-Ab-2
Products NameAnti-KIAA1958 monoclonal antibody
Formatmab
Target NameKIAA1958
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KIAA1958 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2559-Ag-1Recombinant multi-species K1958/ KIAA1958 protein


    Target information

    Target IDGM-IP2559
    Target NameKIAA1958
    Gene ID158405,230259,100361585,707028,481669,101095052,509630,100057130
    Gene Symbol and SynonymsE130308A19Rik,KIAA1958,RGD1310951
    Uniprot AccessionQ8N8K9
    Uniprot Entry NameK1958_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165185
    Target ClassificationN/A

    The target: KIAA1958, gene name: KIAA1958, also named as . 0.



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.